Journal of Materials Chemistry B,
Год журнала:
2023,
Номер
11(36), С. 8605 - 8621
Опубликована: Янв. 1, 2023
Alzheimer's
disease
(AD)
is
a
neurodegenerative
that
causes
memory
and
cognitive
dysfunction
reduces
person's
decision-making
reasoning
functions.
AD
the
leading
cause
of
dementia
in
elderly.
Patients
with
have
increased
expression
pro-inflammatory
cytokines
nervous
system,
sustained
inflammatory
response
impairs
neuronal
function.
Meanwhile,
long-term
use
anti-inflammatory
drugs
can
reduce
incidence
to
some
extent.
This
confirms
anti-neuroinflammation
may
be
an
effective
treatment
for
AD.
Gold
nanoparticles
(AuNPs)
are
emerging
nanomaterial
promising
physicochemical
properties,
antioxidant.
AuNPs
neuroinflammation
by
inducing
macrophage
polarization
toward
M2
phenotype,
reducing
cytokine
expression,
blocking
leukocyte
adhesion,
decreasing
oxidative
stress.
Therefore,
gradually
attracting
interest
scholars
used
treating
diseases
drug
delivery.
Herein,
we
explored
role
mechanism
The
topic
worth
exploring
future,
not
only
help
solve
global
public
health
problem
but
also
provide
reference
other
neuroinflammatory
diseases.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Авг. 23, 2024
Abstract
Alzheimer’s
disease
(AD)
stands
as
the
predominant
form
of
dementia,
presenting
significant
and
escalating
global
challenges.
Its
etiology
is
intricate
diverse,
stemming
from
a
combination
factors
such
aging,
genetics,
environment.
Our
current
understanding
AD
pathologies
involves
various
hypotheses,
cholinergic,
amyloid,
tau
protein,
inflammatory,
oxidative
stress,
metal
ion,
glutamate
excitotoxicity,
microbiota-gut-brain
axis,
abnormal
autophagy.
Nonetheless,
unraveling
interplay
among
these
pathological
aspects
pinpointing
primary
initiators
require
further
elucidation
validation.
In
past
decades,
most
clinical
drugs
have
been
discontinued
due
to
limited
effectiveness
or
adverse
effects.
Presently,
available
primarily
offer
symptomatic
relief
often
accompanied
by
undesirable
side
However,
recent
approvals
aducanumab
(
1
)
lecanemab
2
Food
Drug
Administration
(FDA)
present
potential
in
disrease-modifying
Nevertheless,
long-term
efficacy
safety
need
Consequently,
quest
for
safer
more
effective
persists
formidable
pressing
task.
This
review
discusses
pathogenesis,
advances
diagnostic
biomarkers,
latest
updates
trials,
emerging
technologies
drug
development.
We
highlight
progress
discovery
selective
inhibitors,
dual-target
allosteric
modulators,
covalent
proteolysis-targeting
chimeras
(PROTACs),
protein-protein
interaction
(PPI)
modulators.
goal
provide
insights
into
prospective
development
application
novel
drugs.
Molecules,
Год журнала:
2022,
Номер
27(17), С. 5481 - 5481
Опубликована: Авг. 26, 2022
Despite
advances
in
antimicrobial
and
anti-inflammatory
therapies,
inflammation
its
consequences
still
remain
a
significant
problem
medicine.
Acute
inflammatory
responses
are
responsible
for
directly
life-threating
conditions
such
as
septic
shock;
on
the
other
hand,
chronic
can
cause
degeneration
of
body
tissues
leading
to
severe
impairment
their
function.
Neuroinflammation
is
defined
an
response
central
nervous
system
involving
microglia,
astrocytes,
cytokines
including
chemokines.
It
considered
important
neurodegerative
diseases,
Alzheimer's
disease,
Parkinson's
disease
amyotrophic
lateral
sclerosis.
Lipopolysaccharide
(LPS)
strong
immunogenic
particle
present
outer
membrane
Gram-negative
bacteria.
major
triggering
factor
cascade
bacteria
infection.
The
use
LPS
pro-inflammatory
agent
well-known
model
applied
both
vivo
vitro
studies.
This
review
offers
summary
pathogenesis
associated
with
exposure,
especially
field
neuroinflammation.
Moreover,
we
analyzed
different
models
utilized
area
neuroscience.
paper
presents
recent
knowledge
focused
new
insights
experimental
model.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(7), С. 6518 - 6518
Опубликована: Март 30, 2023
Alzheimer’s
disease
is
one
of
the
most
commonly
diagnosed
cases
senile
dementia
in
world.
It
an
incurable
process,
often
leading
to
death.
This
multifactorial,
and
factor
this
inflammation.
Numerous
mediators
secreted
by
inflammatory
cells
can
cause
neuronal
degeneration.
Neuritis
may
coexist
with
other
mechanisms
disease,
contributing
progression,
also
directly
underlie
AD.
Although
much
has
been
established
about
processes
pathogenesis
AD,
many
aspects
remain
unexplained.
The
work
devoted
particular
pathomechanism
inflammation
its
role
diagnosis
treatment.
An
in-depth
detailed
understanding
neuroinflammation
help
development
diagnostic
methods
for
early
contribute
new
therapeutic
strategies
disease.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(11), С. 6224 - 6224
Опубликована: Июнь 2, 2022
Vascular
cognitive
impairment
and
dementia
(VCID)
is
a
major
heterogeneous
brain
disease
caused
by
multiple
factors,
it
the
second
most
common
type
of
in
world.
It
long-term
chronic
low
perfusion
whole
or
local
area,
eventually
develops
into
severe
dysfunction
syndrome.
Because
disease's
ambiguous
classification
diagnostic
criteria,
there
no
clear
treatment
strategy
for
VCID,
association
between
cerebrovascular
pathology
controversial.
Neuroinflammation
an
immunological
cascade
reaction
mediated
glial
cells
central
nervous
system
where
innate
immunity
resides.
Inflammatory
reactions
could
be
triggered
various
damaging
events,
including
hypoxia,
ischemia,
infection.
Long-term
hypoperfusion-induced
ischemia
hypoxia
can
overactivate
neuroinflammation,
causing
apoptosis,
blood-brain
barrier
damage
other
pathological
changes,
triggering
aggravating
occurrence
development
VCID.
In
this
review,
we
will
explore
mechanisms
neuroinflammation
induced
hypoperfusion
emphasize
important
role
VCID
from
perspective
immune
cells,
mediators
signaling
pathways,
so
as
to
provide
valuable
ideas
prevention
disease.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Дек. 6, 2023
Gut-liver-brain
axis
is
a
three-way
highway
of
information
interaction
system
among
the
gastrointestinal
tract,
liver,
and
nervous
systems.
In
past
few
decades,
breakthrough
progress
has
been
made
in
gut
liver
brain
axis,
mainly
through
understanding
its
formation
mechanism
increasing
treatment
strategies.
this
review,
we
discuss
various
complex
networks
including
barrier
permeability,
hormones,
microbial
metabolites,
vagus
nerve,
neurotransmitters,
immunity,
toxic
β-amyloid
(Aβ)
metabolism,
epigenetic
regulation
gut-liver-brain
axis.
Some
therapies
containing
antibiotics,
probiotics,
prebiotics,
synbiotics,
fecal
microbiota
transplantation
(FMT),
polyphenols,
low
FODMAP
diet
nanotechnology
application
regulate
Besides,
some
special
treatments
targeting
gut-liver
include
farnesoid
X
receptor
(FXR)
agonists,
takeda
G
protein-coupled
5
(TGR5)
glucagon-like
peptide-1
(GLP-1)
antagonists
fibroblast
growth
factor
19
(FGF19)
analogs.
Targeting
gut-brain
embraces
cognitive
behavioral
therapy
(CBT),
antidepressants
tryptophan
metabolism-related
therapies.
liver-brain
contains
Aβ
future,
better
interactions
will
promote
development
novel
preventative
strategies
discovery
precise
therapeutic
targets
multiple
diseases.
Cells,
Год журнала:
2022,
Номер
11(17), С. 2728 - 2728
Опубликована: Сен. 1, 2022
Alzheimer’s
disease
(AD)
is
the
most
common
form
of
dementia
worldwide,
with
a
complex,
poorly
understood
pathogenesis.
Cerebral
atrophy,
amyloid-β
(Aβ)
plaques,
and
neurofibrillary
tangles
represent
main
pathological
hallmarks
AD
brain.
Recently,
neuroinflammation
has
been
recognized
as
prominent
feature
brain
substantial
evidence
suggests
that
inflammatory
response
modulates
progression.
Additionally,
dysregulation
calcium
(Ca2+)
homeostasis
represents
another
early
factor
involved
in
pathogenesis,
intracellular
Ca2+
concentration
essential
to
ensure
proper
cellular
neuronal
functions.
Although
growing
supports
involvement
mechanisms
neurodegeneration-related
processes,
scant
data
are
available
on
its
contribution
microglia
astrocytes
functioning,
both
health
throughout
continuum.
Nevertheless,
AD-related
aberrant
signalling
crucially
underpinning
neuroinflammatory
processes
that,
turn,
impact
function.
In
this
light,
we
attempted
provide
an
overview
current
understanding
interactions
between
glia
cells-mediated
responses
molecular
AD.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(3), С. 2136 - 2136
Опубликована: Янв. 21, 2023
Flavonoids
have
been
shown
to
anti-oxidative
effects,
as
well
other
health
benefits
(e.g.,
anti-inflammatory
and
anti-tumor
functions).
Luteolin
(3′,
4′,
5,7-tetrahydroxyflavone)
is
a
flavonoid
found
in
vegetables,
fruits,
flowers,
herbs,
including
celery,
broccoli,
green
pepper,
navel
oranges,
dandelion,
peppermint,
rosemary.
has
multiple
useful
especially
regulating
inflammation-related
symptoms
diseases.
In
this
paper,
we
summarize
the
studies
about
immunopharmacological
activity
of
luteolin
on
anti-inflammatory,
anti-cardiovascular,
anti-cancerous,
anti-neurodegenerative
diseases
published
since
2018
available
PubMed
or
Google
Scholar.
review,
also
introduce
some
additional
formulations
improve
its
solubility
bioavailability.
Antioxidants,
Год журнала:
2023,
Номер
12(3), С. 753 - 753
Опубликована: Март 20, 2023
Nitric
oxide,
a
ubiquitous
molecule
found
throughout
the
natural
world,
is
key
implicated
in
many
central
and
benefic
molecular
pathways
has
well-established
role
function
of
nervous
system,
as
numerous
studies
have
previously
shown.
Dysregulation
its
metabolism,
mainly
upregulation
nitric
oxide
production,
been
proposed
trigger
and/or
aggravator
for
neurological
affections.
Increasing
evidence
supports
implication
this
prevalent
neurodegenerative
diseases,
such
Parkinson’s
disease,
Alzheimer’s
or
amyotrophic
lateral
sclerosis.
The
mechanisms
neurotoxicity
center
around
increased
quantities
that
are
produced
brain,
their
cause,
and,
most
importantly,
pathological
metabolic
cascades
created.
These
lead
to
formation
neuronal
toxic
substances
impair
neurons’
structure
on
multiple
levels.
purpose
review
present
main
causes
well
important
pathophysiological
triggered
by
could
help
explain
part
complex
picture
diseases
develop
targeted
therapies.